Global Consensus on Active Surveillance for Low-Grade NMIBC
In the evolving landscape of uro-oncology, active surveillance (AS) has emerged as a transformative strategy, particularly for patients diagnosed with low-grade non-muscle-invasive bladder cancer (LG-NMIBC)....
















